Cargando…

The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol

The coronavirus disease 2019 (COVID-19), a pneumonia caused by a novel coronavirus, was reported in December 2019. COVID-19 is highly contagious and has rapidly developed from a regional epidemic into a global pandemic. As yet, no effective drugs have been found to treat this virus. This study, an o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xiaoke, Yu, Kaijiang, Wang, Yongchen, Xu, Wanhai, Ma, Hongli, Hou, Yan, Li, Yue, Cai, Benzhi, Zhu, Liying, Zhang, Min, Hu, Xiaoli, Gao, Jingshu, Wang, Yu, Qin, Huichao, Zhao, Mingyan, Zhang, Yong, Li, Kang, Du, Zhimin, Yang, Baofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	THE AUTHORS. Published by Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company. 2020
Materias:	Research Coronavirus Disease 2019—Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332434/ https://www.ncbi.nlm.nih.gov/pubmed/32837750 http://dx.doi.org/10.1016/j.eng.2020.06.011

Ejemplares similares

Efficacy and Safety of Triazavirin Therapy for Coronavirus Disease 2019: A Pilot Randomized Controlled Trial
por: Wu, Xiaoke, et al.
Publicado: (2020)

Potential Treatment of COVID-19 with Traditional Chinese Medicine: What Herbs Can Help Win the Battle with SARS-CoV-2?
por: Li, Lin, et al.
Publicado: (2022)

Adaptive Wall-Based Attachment Ventilation: A Comparative Study on Its Effectiveness in Airborne Infection Isolation Rooms with Negative Pressure
por: Zhang, Ying, et al.
Publicado: (2022)

Enlightenment from the COVID-19 Pandemic: The Roles of Environmental Factors in Future Public Health Emergency Response
por: Wang, Xiaolei, et al.
Publicado: (2022)

SARS-CoV-2 Entry Factors: ACE2 and TMPRSS2 Are Expressed in Peri-Implantation Embryos and the Maternal–Fetal Interface
por: Chen, Wei, et al.
Publicado: (2020)

Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID)
por: Jin, Xinyao, et al.
Publicado: (2020)

Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity
por: Tang, Lingling, et al.
Publicado: (2020)

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study()
por: Cai, Qingxian, et al.
Publicado: (2020)

Triazavirin—A Novel Effective Antiviral Drug
por: Chupakhin, Oleg N., et al.
Publicado: (2022)

Identification of Monocytes Associated with Severe COVID-19 in the PBMCs of Severely Infected Patients Through Single-Cell Transcriptome Sequencing
por: Zhang, Yan, et al.
Publicado: (2022)

Clinical Characteristics and Outcomes of Severe or Critical COVID-19 Patients Presenting No Respiratory Symptoms or Fever at Onset
por: Xu, Juanjuan, et al.
Publicado: (2021)

A Predictive Nomogram for Predicting Improved Clinical Outcome Probability in Patients with COVID-19 in Zhejiang Province, China
por: Xie, Jiaojiao, et al.
Publicado: (2022)

A second functional furin site in the SARS-CoV-2 spike protein
por: Zhang, Yue, et al.
Publicado: (2022)

A High-Throughput, Multi-Index Isothermal Amplification Platform for Rapid Detection of 19 Types of Common Respiratory Viruses Including SARS-CoV-2
por: Xing, Wanli, et al.
Publicado: (2020)

Natural Host–Environmental Media–Human: A New Potential Pathway of COVID-19 Outbreak
por: Li, Miao, et al.
Publicado: (2020)

Ecological Barrier Deterioration Driven by Human Activities Poses Fatal Threats to Public Health due to Emerging Infectious Diseases
por: Zhang, Dayi, et al.
Publicado: (2022)

The Scientific Foundation of Chinese Herbal Medicine against COVID-19
por: Leung, Elaine Lai-Han, et al.
Publicado: (2020)

A Deep Learning System to Screen Novel Coronavirus Disease 2019 Pneumonia
por: Xu, Xiaowei, et al.
Publicado: (2020)

Development and Validation of a Prognostic Risk Score System for COVID-19 Inpatients: A Multi-Center Retrospective Study in China
por: Yuan, Ye, et al.
Publicado: (2022)

Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment
por: Chen, Jiajia, et al.
Publicado: (2020)

Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications
por: Sun, Zeyu, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes of Type 2 Diabetes Patients Infected with COVID-19: A Retrospective Study
por: Chen, Yingyu, et al.
Publicado: (2020)

Implementation of Clinical Diagnostic Criteria and Universal Symptom Survey Contributed to Lower Magnitude and Faster Resolution of the COVID-19 Epidemic in Wuhan
por: Wei, Yongyue, et al.
Publicado: (2020)

Ultrasonic Characteristics and Severity Assessment of Lung Ultrasound in COVID-19 Pneumonia in Wuhan, China: A Retrospective, Observational Study
por: Zhu, Fengxue, et al.
Publicado: (2021)

Can Masks Be Reused After Hot Water Decontamination During the COVID-19 Pandemic?
por: Wang, Dan, et al.
Publicado: (2020)

Buying Time for an Effective Epidemic Response: The Impact of a Public Holiday for Outbreak Control on COVID-19 Epidemic Spread
por: Chen, Simiao, et al.
Publicado: (2020)

Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell–cell fusion, and neutralization sensitivity
por: Zhang, Li, et al.
Publicado: (2022)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
por: Ao, Ling, et al.
Publicado: (2022)

Strategies and Advances in Combating COVID-19 in China
por: Liu, Wei, et al.
Publicado: (2020)

Roadmap for Managing SARS-CoV-2 and Other Viruses in the Water Environment for Public Health
por: Liu, Gang, et al.
Publicado: (2022)

Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants
por: Yan, Qihong, et al.
Publicado: (2022)

Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial
por: Jin, Lairun, et al.
Publicado: (2022)

Omicron infections profile and vaccination status among 1881 liver transplant recipients: a multi-centre retrospective cohort
por: Ma, Ensi, et al.
Publicado: (2022)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
por: Li, Tao, et al.
Publicado: (2023)

Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai
por: Wu, Qianhui, et al.
Publicado: (2023)

Sera from breakthrough infections with SARS-CoV-2 BA.5 or BF.7 showed lower neutralization activity against XBB.1.5 and CH.1.1
por: Liu, Shuo, et al.
Publicado: (2023)

Safety, mucosal and systemic immunopotency of an aerosolized adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques
por: Xu, Fang, et al.
Publicado: (2022)

Single cell characteristics of patients with vaccine-related adverse reactions following inactivated COVID-19 vaccination
por: Jiang, Manling, et al.
Publicado: (2023)

Orthogonal dual reporter-based gain-of-signal assay for probing SARS-CoV-2 3CL protease activity in living cells: inhibitor identification and mutation investigation
por: Bei, Zhu-Chun, et al.
Publicado: (2023)

Aggravated pneumonia and diabetes in SARS-CoV-2 infected diabetic mice
por: Huang, Qing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_23jas0t69j7bhgbr453f27lbin